A study has demonstrated that the upregulation of KRT7 in pancreatic cancer is associated with the expression of immune checkpoints, including CD274, CD276, HAVCR2 (hepatitis A virus cellular receptor 2), and VTCN1 (Figure 3) (64). Here, KRT7 is linked to pancreatic neoplasm.